Answers are grounded in this paper and cite their sources.
The safety and efficacy of topiramate (400 mg/d or maximum tolerated dose) as monotherapy or adjunctive treatment of essential tremor were investigated in a placebo-controlled, crossover study (n = 24). Topiramate resulted in significantly greater reductions from baseline based on normalized scores for a clinical rating of tremor location/severity, specific motor tasks/functional disabilities, and tremor-resultant functional disabilities. Most common adverse events were appetite suppression/weight loss and paresthesias.
No takes yet. Share an insight, caveat, or question.
Gregory S. Connor (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: